SONOMA PHARMACEUTICALS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 6-month period ending 2020-09-30, per its 10-Q filed 2020-11-20.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2020-11-20
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-12-31 was 0.00 shares.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-09-30 was 135.00K shares, a 154.72% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-06-30 was 24.00K shares, a 95.03% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2016 was 1.42M shares, a 270.05% increase from fiscal 2015.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2015 was 384.00K shares, a 76.70% decline from fiscal 2014.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2014 was 1.65M shares, a 1229.03% increase from fiscal 2013.
- SONOMA PHARMACEUTICALS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2013 was 124.00K shares, a 39900.00% increase from fiscal 2012.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-20 | ||||
| 2019-12-31 | 268.00K shares 10-Q · filed 2020-02-14 | ||||
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-13 | ||||
| 2018-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | 135.00K shares derived: sum of 2 quarters · filed 2019-02-14 | 159.00K shares 10-Q · filed 2019-02-14 | ||
| 2018-09-30 | 135.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | 159.00K shares 10-Q · filed 2018-11-08 | |||
| 2018-06-30 | 24.00K shares 10-Q · filed 2018-08-08 | ||||
| 2017-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-14 | 53.00K shares derived: sum of 2 quarters · filed 2018-02-14 | 536.00K shares 10-Q · filed 2018-02-14 | ||
| 2017-09-30 | 53.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-14 | 536.00K shares 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | 483.00K shares 10-Q · filed 2017-08-08 | ||||
| 2016-12-31 | 110.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-17 | 119.00K shares derived: sum of 2 quarters · filed 2017-02-17 | 135.00K shares 10-Q · filed 2017-02-17 | 349.00K shares derived: sum of 4 quarters · filed 2017-02-17 | |
| 2016-09-30 | 9.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-15 | 25.00K shares 10-Q · filed 2016-11-15 | 239.00K shares derived: sum of 3 quarters · filed 2016-11-15 | 279.00K shares derived: sum of 4 quarters · filed 2016-11-15 | |
| 2016-06-30 | 16.00K shares 10-Q · filed 2016-08-09 | 230.00K shares derived: sum of 2 quarters · filed 2016-08-09 | 270.00K shares derived: sum of 3 quarters · filed 2016-08-09 | 1.28M shares derived: sum of 4 quarters · filed 2016-08-09 | |
| 2016-03-31 | 214.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-21 | 254.00K shares derived: sum of 2 quarters · filed 2016-06-21 | 1.27M shares derived: sum of 3 quarters · filed 2016-06-21 | 1.42M shares 10-K · filed 2016-06-21 | |
| 2015-12-31 | 40.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | 1.05M shares derived: sum of 2 quarters · filed 2016-02-16 | 1.21M shares 10-Q · filed 2016-02-16 | ||
| 2015-09-30 | 1.01M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-10 | 1.17M shares 10-Q · filed 2015-11-10 | |||
| 2015-06-30 | 155.00K shares 10-Q · filed 2015-08-07 | ||||
| 2015-03-31 | 384.00K shares 10-K · filed 2015-06-16 | ||||
| 2014-06-30 | 0.00 shares 10-Q · filed 2014-08-12 | 1.29M shares derived: sum of 2 quarters · filed 2014-08-12 | 1.31M shares derived: sum of 3 quarters · filed 2014-08-12 | ||
| 2014-03-31 | 1.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | 1.31M shares derived: sum of 2 quarters · filed 2014-06-30 | 1.65M shares 10-K · filed 2014-06-30 | ||
| 2013-12-31 | 27.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | 362.00K shares 10-Q · filed 2014-02-14 | |||
| 2013-09-30 | 335.00K shares 10-Q · filed 2013-11-19 | ||||
| 2013-03-31 | 123.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | 124.00K shares 10-K · filed 2014-06-30 | 124.00 shares 10-K · filed 2013-06-25 | ||
| 2012-12-31 | 820.00 shares 10-Q · filed 2013-02-13 | ||||
| 2012-03-31 | 310.00 shares 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |